UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048280
Receipt number R000055017
Scientific Title The effect of everyday life physical activity on creative thinking
Date of disclosure of the study information 2022/07/05
Last modified on 2024/07/08 14:01:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of everyday life physical activity on creative thinking

Acronym

The effect of everyday life physical activity on creative thinking

Scientific Title

The effect of everyday life physical activity on creative thinking

Scientific Title:Acronym

The effect of everyday life physical activity on creative thinking

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether everyday life physical activity, such as stair-climbing, affects creative thinking. In addition, to investigate whether the effect of everyday life physical activity on creative thinking depends on post-physical activity mood and subjects' personal characteristics

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Divergent thinking, as evaluated by the alternate uses test.
Convergent thinking, as evaluated by the matchstick puzzle.

Key secondary outcomes

1), whether the effect of physical activity depends on heart rate during and mood after the intervention
2), whether the effect of physical activity depends on regular physical activity, handgrip strength, mental health, and other personal characteristics
3), as additional data analysis, we will investigate the association between personal characteristics


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

4

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Exercise (Stair-climbing 2 floors up): starting from the 7th floor of our research building move to the 9th floor where our laboratory is located, at one's usual paces using stairs

Interventions/Control_2

Exercise (Stair-climbing 5 floors up): starting from the 4th floor of our research building move to the 9th floor where our laboratory is located, at one's usual paces using stairs

Interventions/Control_3

Exercise (Stair-climbing 8 floors up): starting from the 1th floor of our research building move to the 9th floor where our laboratory is located, at one's usual paces using stairs

Interventions/Control_4

Control (Elevator 8 floors up): starting from the 1th floor of our research building move to the 9th floor where our laboratory is located, at one's usual paces using the elevator

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

29 years-old >=

Gender

Male and Female

Key inclusion criteria

Those who can provide written informed consent after receiving a detailed explanation of the study

Key exclusion criteria

1), being diagnosed with any mental disorders, receiving or being scheduled to receive medical examinations due to suspicion of mental disorders.
2), having attended our previous studies on exercise/physical activity and creative thinking.
3), staff of our department who receive personnel assessment from the principle investigator of the study.
4), people judged inappropriate to be subjects of the study

Target sample size

52


Research contact person

Name of lead principal investigator

1st name Shin
Middle name
Last name Nakagawa

Organization

Yamaguchi University Graduate School of Medicine

Division name

Division of Neuropsychiatry, Department of Neuroscience

Zip code

755-8505

Address

Minami-kogushi 1-1-1, Ube, Japan

TEL

0836-22-2254

Email

brain@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Chong
Middle name
Last name Chen

Organization

Yamaguchi University Graduate School of Medicine

Division name

Division of Neuropsychiatry, Department of Neuroscience

Zip code

755-8505

Address

Minami-kogushi 1-1-1, Ube, Japan

TEL

0836-22-2254

Homepage URL


Email

brain@yamaguchi-u.ac.jp


Sponsor or person

Institute

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center For Clinical Research, Yamaguchi University Hospital

Address

Minami-kogushi 1-1-1, Ube, Japan

Tel

0836-22-2428

Email

clin_res@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山口大学医学部附属病院
Yamaguchi University Hospital


Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2022 Year 06 Month 02 Day

Date of IRB

2022 Year 06 Month 30 Day

Anticipated trial start date

2022 Year 07 Month 06 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 07 Month 05 Day

Last modified on

2024 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055017